Companies

Makes the Gastric Alimetry System, a wearable body-surface patch plus symptom-logging app that non-invasively maps stomach electrical activity to diagnose gastroparesis, reflux, functional dyspepsia and chronic nausea.

Develops regenerative-medicine biomaterials from ovine forestomach matrix (OFM) for wound healing, soft-tissue reconstruction and hernia repair — Endoform, Myriad and Ovitex product lines.

Global market leader in implantable hearing solutions — Nucleus cochlear implants, Hybrid electro-acoustic implants and Baha bone-conduction implants — commercializing technology pioneered by Dr Graeme Clark.

Develops and manufactures diagnostic systems for sleep medicine, neurology/EEG, magnetoencephalography and ultrasonic blood-flow monitoring; holds roughly 80% of the Australian sleep-diagnostics market.

Regenerative-medicine company developing allogeneic cell therapies from mesenchymal lineage cells (MPCs/MSCs) for inflammatory disease, cardiovascular disease and back pain.

Makes trophon, automated high-level disinfection technology for ultrasound probes, plus trophon2 with digital record-keeping (AcuTrace) for infection-control workflow.

Antibody discovery and development company running an integrated platform — single-cell screening through preclinical and clinical manufacturing — that has completed 100+ partnered antibody-discovery programs and now advances its own pipeline.

Agentic AI research platform used by pharma R&D teams to mine biomedical literature and antibody/reagent data to accelerate preclinical drug discovery.

B2B virtual healthcare platform offering employer-sponsored telemedicine, mental health, and wellness programs across Canada and (via its Tictrac acquisition) Europe.

Genetic-medicines company developing non-viral gene therapies delivered directly to mucosal tissues; lead program is a bladder-instilled gene therapy for non-muscle invasive bladder cancer.

Develops ReSolv, an investigational polymer-based bioresorbable stent that diverts blood flow to heal brain aneurysms, spun out of University of Calgary neurosurgery research.

Developed next-generation targeted alpha-particle radiopharmaceuticals for cancer, linking alpha-emitting isotopes to cancer-targeting molecules via proprietary Fast-Clear linker technology.

Delivers virtual mental health services (therapist matching and online counselling) through its platform.

AI-powered health platform ('agent teams' / Forge by League) that lets payers, providers, and employers build personalized consumer health benefits and virtual-care experiences.

Developed plant-derived virus-like-particle vaccines, using Nicotiana benthamiana leaves as bioreactors to produce vaccine candidates in about a month via its Proficia technology.

Cloud compliance infrastructure for digital health companies, providing built-in policy templates and developer tools to meet HIPAA, GDPR, SOC 2, PIPEDA, and PHIPA requirements.

Digital mental health platform delivering therapist-guided and self-guided Cognitive Behavioural Therapy (CBT), first launched in-clinic in 2016 and fully digitally in 2017.

Fluorescence-guided imaging devices that detect elevated bacterial loads in wounds in real time, used in wound care and formerly in surgical oncology.

Patient portal that gives patients secure online access to and sharing of their medical imaging records from hospitals and clinics, now expanding into AI-powered risk-assessment tools.

Develops femtosecond-laser technology to image and non-invasively treat vitreoretinal eye disease, initially targeting symptomatic eye floaters.

Clinical-stage precision oncology company using its SNIPRx synthetic-lethality discovery platform to build a DNA damage response-focused drug pipeline.

AI-powered wound care management platform (Swift Skin & Wound) that analyzes smartphone wound images to give clinical assessments and coordinate care across home health, hospitals, and nursing facilities.

Clinical-stage immuno-oncology company developing SIRPα-Fc fusion proteins designed to enhance the innate immune system's ability to detect and destroy cancer cells.

Owns and operates outpatient primary-care clinics across Canada and the US while providing SaaS electronic medical records, telemedicine, billing, and cybersecurity services to healthcare providers.

Biotechnology company developing multifunctional protein therapeutics — bispecific antibodies and antibody-drug conjugates — for oncology, autoimmune, and inflammatory diseases.

Clinical-stage biopharmaceutical company using its SupraAntigen (active immunotherapy) and Morphomer (small-molecule) platforms to diagnose, treat and prevent neurodegenerative diseases.

Treatments for rare and orphan diseases, notably pulmonary arterial hypertension (PAH).

In-vitro diagnostics company making CE-marked point-of-care tests (the QuikRead go system) for infectious disease, diabetes management and colorectal-cancer screening.

Specialized in alpha-particle emitting radiopharmaceuticals for cancer treatment; developed the first marketed alpha-emitter radiopharmaceutical.

Danish company specializing in the development and manufacturing of allergy immunotherapy (AIT) products for the prevention and treatment of allergy.

Swiss life-science company that discovered and commercializes Mitopure (Urolithin A), a clinically validated cellular nutrient that triggers mitophagy to support healthy aging, sold via its Timeline consumer brand and through B2B ingredient partnerships.

Makes single-use endoscopy solutions, diagnostic and life-supporting equipment, including the Ambu Bag resuscitator and single-use videoscopes.

Develops rationally designed 'Targeted Glues' — next-generation targeted protein degradation therapeutics.

One of Romania's largest drug producers, manufacturing ~150 medicines across 12 therapeutic areas plus veterinary products and the active substance Nystatin.

Immunotherapy and oncology drug developer, translating academic research (Josef Penninger's lab) into cancer therapeutics.

Biopharmaceutical company built on the TransCon drug-conjugation technology platform, focused on rare endocrinology and other severe diseases.

Clinical-stage (commercial) biopharmaceutical company engineering next-generation CAR T-cell therapies for cancer and autoimmune disease.

Precision gene-therapy company translating neuroscience from King's College London and the UK Dementia Research Institute into treatments for neurodegenerative disease.

Surgical instruments, infusion systems and dialysis equipment.

Drugs for severe, resistant bacterial infections and life-threatening invasive fungal diseases.

Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines, including smallpox/mpox and Ebola.

Pharmaceuticals and biotechnology company; prescription products for women's healthcare, cardiology, oncology, hematology and ophthalmology (also a diversified crop-science/consumer-health group).

Clinical-stage biotech using AAV gene therapy to treat rare and prevalent retinal diseases.

Private general-hospital network offering outpatient exams, diagnostics, surgery and inpatient care across five interconnected Belgrade locations.

mRNA-based immunotherapies and vaccines company, developing cancer treatments and infectious-disease vaccines; co-developed the Comirnaty COVID-19 vaccine with Pfizer.

Cardiac rhythm management, cardiac monitoring, electrophysiology and neuromodulation devices.

Human pharmaceuticals, animal health and biopharmaceuticals, with focus on respiratory, metabolism, immunology, oncology and CNS.

Develops nanoscale drug-delivery systems (FluidCrystal technology) for sustained release of peptides, proteins and small molecules.

CRISPR-Cas gene-editing technology company, founded by pioneering CRISPR-Cas9 scientists, offering nuclease engineering, mRNA synthesis/optimization, protein evolution and custom gene-editing solutions for therapeutics, diagnostics, agri-tech and industrial biotech.

Genetic-diagnostics and DNA-sequencing services, covering both patient diagnostics and pharma/research sequencing.

Family-controlled pharma developing respiratory, neonatology and rare-disease drugs, plus musculoskeletal treatments.

Makes medical devices for ostomy care, continence and urology care, and wound/skin care.

Develops psilocybin-based, psychedelic-assisted therapy for treatment-resistant depression and other mental health conditions.

CRISPR gene-editing therapeutics for rare and common diseases including sickle cell disease, beta thalassemia, cancers, type 1 diabetes and cardiovascular conditions.

Develops therapies and vaccines based on messenger RNA (mRNA) for infectious disease, cancer and rare diseases.

Population-scale human genetics research company that identifies genome variations associated with common diseases, leveraging Iceland's genealogical and health-data records.

Hearing-care group manufacturing hearing aids and audiometric equipment under the Oticon, Bernafon, Interacoustics and Maico brands, plus Audika/HearingLife retail clinics.

Manufactures in-vitro diagnostic reagent kits for immunodiagnostics and molecular diagnostics; expanded into life-science tools via its 2021 acquisition of Luminex Corporation.

Develops radiation therapy and radiosurgery equipment for cancer treatment and brain disorders.

Supplier of electronic patient record software (EMIS Web) used across UK primary care, acute care and community pharmacy; more than half of UK GP practices ran its systems.

Discovers 'Dark Antigens' from the non-coding genome and develops bispecific T-cell engagers against them for solid-tumour cancer immunotherapy.

Drug-discovery company developing muco-regulatory small molecules (ENaC blockers) that increase mucus hydration and clearance for respiratory disease.

DNA-methylation-based molecular diagnostics for cancer detection: Epi proColon (colon cancer, blood-based) and Epi proLung (lung cancer, bronchial fluid).

Clinical-stage oncology company developing IgE-, IgA- and IgG-based antibody therapeutics with differentiated immune mechanisms.

R&D pharma focused on pain and other areas of unmet therapeutic need, plus active-pharmaceutical-ingredient and fine-chemistry manufacturing.

Drug discovery and development company operating as a contract research organization (CRO/CDMO), partnering with pharma and biotech on early-stage R&D.

Develops exosome-based drug-delivery (DeliverEX platform) to deliver genome-editing and other genetic medicines across biological barriers for neurodegenerative and rare disease.

Multinational pharma/biotech producing medicines in neuroscience, oncology, women's health and cardiovascular, plus biosimilars.

Produces and distributes medical products and equipment for the healthcare and life-sciences industries, including surgical, critical-care and sterilization equipment.

Hearing and audio group making hearing aids (GN Hearing/ReSound) and professional headsets (Jabra); also owns gaming brand SteelSeries.

Pharmaceutical manufacturer of cardiovascular, CNS, oncology and diabetes medicines plus generics and active pharmaceutical ingredients, exporting to 90+ countries.

Develops precision therapies for neurodegenerative disease on its MISBA platform, which enables controlled modulation of CNS targets via RNA biology.

Serbia's leading pharmaceutical manufacturer, producing prescription and OTC medicines and accounting for the majority of the country's pharma exports.

Family-owned biotech-pharma group developing, manufacturing and commercializing biological products for animal health (100+ vaccines) and human health (COVID-19 vaccine, digestive health), plus contract biotech-manufacturing services.

CDMO specializing in active pharmaceutical ingredient (API) development/manufacturing, inhalation products and particle engineering.

Pharmaceutical research company spun off from Actelion's R&D unit after the Johnson & Johnson acquisition.

Commercial-stage biotechnology company developing soluble T-cell receptor (TCR) bispecific drugs for cancer, infectious disease and autoimmune disease.

Wound-care and tissue-regeneration products derived from decellularized Atlantic cod fish skin, used as skin grafts.

International generic-pharmaceutical group producing prescription drugs, OTC products and animal-health medicines, marketed in 70+ countries; also runs the Terme Krka health-resort subsidiary.

Video-consultation telemedicine platform (branded Kry in Sweden/Norway, Livi elsewhere) connecting patients with doctors, plus a network of physical clinics.

Greek pharmaceutical company developing, manufacturing, marketing and distributing pharmaceutical, cosmetic, veterinary and consumer-health products across Greece, France, Cyprus and the US.

Contract development and manufacturing organization (CDMO) for pharma, biotech and nutrition, including monoclonal antibody and cell/gene-therapy manufacturing.

Uses its ENIGMAC platform to build genetic models of disease and develop macrophage-directed therapeutics for tumours, neurological, fibrotic and inflammatory disease.

Hearing implants and devices: cochlear implants, middle-ear implants and bone-conduction systems.

Science and technology company across Healthcare (oncology, neurology, immunology drugs), Life Sciences (lab/bioprocessing, as MilliporeSigma in North America) and Electronics.

Immunology company developing agonist antibody programmes that target fibroblast biology and tertiary lymphoid structures to treat cancer and inflammatory disease.

Cell separation (MACS magnetic-activated cell sorting), flow cytometry, cell culture and molecular analysis tools, plus cell-therapy manufacturing equipment.

Designed ankyrin repeat proteins (DARPins) — small-protein binders for research, diagnostics and therapy, in oncology, immuno-oncology, ophthalmology and infectious disease.

Clinical-stage biotech discovering small-molecule drugs for neoplastic and inflammatory disease.

Biopharmaceutical company specializing in antibody, protein and peptide technologies for cancer and autoimmune disease drug discovery.

Fertility-tracking app that uses daily basal body temperature readings and an algorithm to indicate fertile/non-fertile days, marketed and cleared as a form of contraception.

AI-powered preventive-health clinics: a ~15-minute non-invasive full-body scan (70+ sensors, tens of millions of data points) screening for cardiovascular, metabolic and skin-cancer risk, followed by an in-person doctor consultation.

Develops NLRP3 inflammasome inhibitors for cardiometabolic and neuroinflammatory diseases.

Swiss multinational pharmaceutical corporation manufacturing prescription drugs and diagnostics, historically also generics/vaccines/animal health (Sandoz generics spun off in 2023).

Develops, manufactures and markets human and veterinary pharmaceuticals plus active pharmaceutical ingredients, with manufacturing and most R&D based in Finland.

World market leader in prosthetics, orthotics, wheelchairs and exoskeletons.

Smart ring that tracks sleep, activity and biometrics (heart rate, body temperature, respiratory rate) via infrared LEDs and sensors, paired with an app.

Develops and sells nanopore DNA/RNA sequencing products, including the portable MinION sequencer, for direct electronic analysis of single molecules.

Oncology and CNS pharma developing marine-derived cancer drugs; subsidiaries Genomica (molecular diagnostics for infectious disease) and Sylentis (RNA-silencing therapeutics).

Maker of heart-rate monitors, sports watches and fitness wearables; invented the first wireless ECG heart-rate monitor.

Engineers regulatory T-cell (Treg) therapies to durably transform immune-mediated and inflammatory diseases, including a collaboration with AstraZeneca on type 1 diabetes and IBD.

Develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and related point-of-care IT systems.

Diagnostics manufacturer developing reagents and equipment for laboratory medicine, plus its own Randox Health clinical-testing service, spanning hospitals, clinical research, food testing, forensic toxicology and veterinary applications across 145 countries.

Contract development and manufacturing organisation (CDMO) providing sterile fill & finish, oral solid dosage, and biologics manufacturing services to pharma customers worldwide.

Global healthcare company operating two divisions: Pharmaceuticals (incl. oncology, HIV) and Diagnostics (applied science, professional diagnostics, diabetes care, molecular and tissue diagnostics).

Generic pharmaceuticals and biosimilars, the self-described world leader in the category.

Supplies bioprocess and laboratory equipment for biopharmaceutical manufacturing and research.

Medical imaging IT (PACS/VNA for radiology and pathology) and encrypted communication systems, spun out of Linköping University.

Medical imaging and diagnostics: CT scanners, ultrasound systems, laboratory diagnostics and molecular imaging.

Develops short-interfering RNA (siRNA) therapeutics on its mRNAi GOLD platform to silence disease-associated genes in the liver.

Immunometabolism biopharmaceutical company developing disease-modifying oral therapies for autoimmune and inflammatory disease by intervening in immune-cell metabolism.

Develops treatments in haematology, immunology and specialty care, concentrating on rare disease therapeutics.

Hearing care: hearing instruments, cochlear implants and wireless communication devices.

AI-driven genomic and radiomic analysis software platform (Sophia DDM) for hospitals, labs and biopharma.

Clinical-stage cancer immunotherapy company developing an IL-15 superagonist and next-generation antibody-drug conjugates.

Clinical-stage vaccine company using its proprietary SpyTag/SpyCatcher protein-superglue technology to build vaccines against infectious disease and cancer.

Dental implants and related technologies: prosthetics, orthodontics and digital dentistry.

AI-integrated digital physical-therapy platform pairing wearable motion sensors with a clinical care team to treat musculoskeletal pain, pelvic health and injury prevention.

Greece's largest integrated pharmaceutical company, developing, manufacturing, marketing and distributing pharmaceutical, cosmetic, veterinary and consumer-health products.

Hearing-aid manufacturer formed by the 2019 merger of Danish Widex and German/Singaporean Sivantos Group, selling under Widex, Signia, Rexton and other brands.

Generic and OTC pharmaceutical manufacturer and marketer, with manufacturing sites in Prague, Bucharest and Ankleshwar (India).

Non-invasive orthopedic devices including bracing and support products, compression therapy, and prosthetics.

Internet pharmaceutical and healthcare company operating a B2C medical e-commerce site, an internet hospital, and a B2B pharmaceutical supply platform.

Oncology-focused biopharmaceutical company researching, discovering, and developing small-molecule pharmaceutical products in Mainland China and the EU.

Operator of the largest private ophthalmology hospital chain in China, with international expansion into Europe, Southeast Asia, and the US.

AI-powered retinal-imaging screening for diabetic retinopathy, chronic-disease early screening, and myopia control.

Biopharmaceutical developer of bispecific and monoclonal antibodies for cancer, best known for ivonescimab, a PD-1/VEGF bispecific.

Online pharmacy and digital-health services operator, majority-owned by Alibaba Group, running Tmall's pharmacy business and health-data services.

Premium multi-disciplinary private hospital group that grew from a high-end obstetrics/pediatrics specialty hospital into oncology, reproductive medicine, orthopedics, and medical aesthetics.

Premium dental-clinic chain offering implants, orthodontics and general dentistry across mainland China.

Global commercial-stage biopharmaceutical company developing apoptosis-targeted therapies for cancers, chronic hepatitis B, and age-related disease.

Multinational oncology company developing and commercializing cancer drugs, founded in Beijing; best known for BTK inhibitor zanubrutinib (Brukinsa), the first China-developed cancer drug to win FDA approval.

Therapeutic drug developer targeting malignant tumors, diabetes, and cardiovascular/cerebrovascular disease; developer of China's first domestically-developed targeted anti-cancer drug.

Develops therapies for infectious and central nervous system diseases in China and the US, with a focus on hepatitis B functional cure.

Biopharmaceutical company researching, developing, and commercializing therapies for rare diseases and oncology worldwide.

Vaccine developer and manufacturer, known for Convidecia, a single-dose viral-vector COVID-19 vaccine.

Discovers, develops, and commercializes CAR-T cell therapies for blood cancers, solid tumors, and autoimmune disease.

Online community and knowledge platform for physicians and healthcare professionals, with an affiliated telemedicine app (丁香医生) and biomedical e-commerce/recruitment arms.

Life-science research tools and services company spanning CDMO, life-science products, and integrated cell therapy (via subsidiary Legend Biotech) and industrial synthetic biology products.

IVD equipment supplier spanning chemiluminescence immunoassay analyzers and point-of-care testing devices for hematology, clinical chemistry, coagulation, molecular diagnostics and veterinary diagnostics.

Contract research organization (CRO) providing clinical trial operations, regulatory affairs, medical translation, pharmacovigilance, and real-world research for innovative drugs, generics, and medical devices.

Online medical-consultation and patient-doctor matching platform that expanded from disease information into paid diagnosis/treatment and an internet-hospital license.

Develops and commercializes drugs for the treatment of Type 2 diabetes in China.

Discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases, majority-owned by CK Hutchison.

Private health-screening chain formed by the 2007 merger of Guobin Health Checkups and Aikang.com, running physical-examination centers across dozens of Chinese cities.

Biopharmaceutical company discovering, developing, and commercializing drugs for cancer and autoimmune diseases in China.

Chinese biopharmaceutical company developing monoclonal antibodies for immuno-oncology, with a fast-growing GLP-1 franchise for weight loss and diabetes.

AI-driven drug discovery company combining generative AI, genomics, and deep learning (Pharma.AI, Chemistry42) to design and develop novel therapeutics.

In-house discovery and development of oncology therapies, notably RAS-pathway inhibitors, in China.

Online pharmacy, internet-hospital, and health-services platform spun out of JD.com's health business.

Online mental-health platform matching users with licensed counselors/psychiatrists, plus offline counseling centers and enterprise EAP services.

China's largest listed pharmaceutical company, manufacturing oncology, cardiovascular, and pain therapeutics, with a growing biologics and ADC-licensing pipeline to Western pharma.

Assisted-reproduction and fertility clinic chain offering fertility assessment, reproductive surgery, and IVF-related services.

Preclinical and non-clinical CRO providing drug safety and pharmacology studies, clinical trial services, and research model sales.

Mobile fitness app offering workout videos, GPS activity tracking, social features, and exercise-equipment e-commerce.

Biotechnology company discovering and developing biological therapies for autoimmune and oncology indications.

Develops small-molecule and biologic drugs targeting androgen-receptor pathways for dermatology and oncology.

End-to-end cell therapy company that discovers, develops, manufactures, and commercializes CAR-T therapies for hematologic and solid tumors; originated as a GenScript subsidiary.

Clinical-information and continuing-medical-education platform for practicing physicians, with drug-reference and guideline databases.

China's largest professional health-screening (physical examination) chain, offering health consulting, assessment and management services.

Diabetes management device maker — patch insulin pump and continuous glucose monitoring (CGM) systems.

In-vitro diagnostics maker specializing in chemiluminescence immunoassay analyzers (MAGLUMI series) plus biochemistry and coagulation analyzers.

Structural heart disease and cerebrovascular intervention device maker — TAVR/transcatheter valve systems (TaurusMax, TaurusTrio) plus hemorrhagic/ischemic neurovascular products.

Mobile platform for online consultations, hospital referrals/appointments, health management, and pharmacy delivery, majority-owned by Ping An Group.

Medical-crowdfunding and health-mutual-aid platform distributing campaigns via WeChat/Alipay, and now also an insurance-distribution business.

Biologics company developing first-in-class antibody-drug conjugates and dual-target biologics for autoimmunity, oncology, and ophthalmology.

Integrated biopharmaceutical company developing and commercializing monoclonal-antibody biologics across oncology, autoimmune, metabolic, and infectious disease; developer of toripalimab, China's first domestically-produced anti-PD-1.

Blood-glucose monitoring device maker (BGM meters, blood-pressure monitors, and the iCan continuous glucose monitoring system).

Vaccine developer, manufacturer, and commercializer focused on protection against human infectious diseases; developer of the CoronaVac inactivated COVID-19 vaccine.

China's first listed dental-focused healthcare group, operating a chain of dental hospitals and clinics.

Premium private hospital and clinic network (United Family Healthcare brand) covering women's health, pediatrics, oncology and rehabilitation across dozens of Chinese cities.

Makes transcatheter heart valve devices (TAVR/TAVI and related surgical accessories) for aortic, pulmonary, mitral and tricuspid valve disease.

Contract research and development/manufacturing organization (CRO/CDMO) providing drug discovery, development, and manufacturing services for small molecules, peptides, and more.

Open-access biologics CDMO offering integrated technology platforms for biologics drug development and manufacturing.

Fully integrated biopharmaceutical company discovering, licensing, and commercializing therapies in oncology, immunology, neuroscience, and infectious disease for the China market.

AI-powered radiology workflow platform (cloud PACS) automating chest X-ray analysis, especially TB and COVID-19 screening.

Digital therapeutics company delivering personalized coaching programs to manage diabetes, obesity and other metabolic/cardiac conditions.

Makes affordable, portable AI-assisted retinal-imaging and refraction devices (3nethra range) designed for rural and low-resource eye-care screening.

Deep-learning AI that reads medical images (chest X-ray, brain CT) to detect and triage diseases including lung cancer, tuberculosis and stroke for clinicians worldwide.

Clinical-stage biopharmaceutical company that identifies, in-licenses and advances drug candidates through clinical development, led by motixafortide (Aphexda), a CXCR4 antagonist for stem-cell mobilization in multiple myeloma.

Clinical-stage biopharmaceutical company developing orally bioavailable small-molecule A3 adenosine-receptor agonists (piclidenoson, namodenoson) for cancer, liver inflammatory disease and other indications.

Clinical-stage biotech developing nebokitug, a monoclonal antibody targeting CCL24, for fibrotic and inflammatory diseases including primary sclerosing cholangitis, systemic sclerosis and rheumatoid arthritis.

Computational-biology and immuno-oncology company that uses its Unigen AI/ML target-discovery platform to find novel immune-checkpoint targets and develop first-in-class antibody therapeutics.

Clinical-stage immunotherapy company developing Allocetra, a universal off-the-shelf cell therapy that reprograms macrophages into a homeostatic state, for indications including knee osteoarthritis and sepsis.

Develops oral tablet-format peptide and protein-replacement therapies using its N-Tab absorption platform, led by EB613 (oral PTH) for osteoporosis and EB612 for hypoparathyroidism.

Computational-biology company applying AI/ML generative-design platforms to discover small molecules and biological products for pharma and agriculture; human-health work is run through subsidiary Biomica (microbiome therapeutics).

Pioneer of capsule endoscopy (PillCam) and capsule-based pH monitoring for visualizing and detecting disorders of the gastrointestinal tract.

Medical devices for diagnosing sleep disorders (WatchPAT, home sleep apnea testing) and assessing early cardiovascular disease (EndoPAT).

Specialty biopharmaceutical company that researches, manufactures and commercializes plasma-derived and other biologic therapeutics, led by Glassia (Alpha-1 Antitrypsin) for AATD.

Made a robotic guidance system for spine surgery.

Fully integrated biopharmaceutical company developing enzymatic, non-surgical tissue-repair therapeutics, led by NexoBrid (eschar removal in burns) and EscharEx (chronic-wound debridement, Phase 3).

AI-powered clinical copilot that helps primary-care clinicians and care teams with value-based care workflows: risk adjustment, quality management, and clinical documentation.

Wearable AI-powered assistive devices for people with visual impairment (OrCam MyEye) and, more recently, hearing assistance (OrCam Hear).

Develops placental-stromal-cell (PLX) therapeutics for ischemic, inflammatory and hematologic conditions.

Biopharmaceutical company using its proprietary PLEX polymer-lipid encapsulation matrix to develop prolonged, locally administered therapeutics, led by D-PLEX100 for preventing surgical-site infections.

Uses its ProCellEx plant-cell-based protein expression system to manufacture recombinant biopharmaceuticals, led by taliglucerase alfa (Elelyso) for Gaucher disease.

Clinical-stage oncology company developing bispecific/tri-specific antibodies and small molecules (CM24, NT219, CAPTN-3) to overcome tumor immune evasion and drug resistance.

Specialty biopharmaceutical company focused on gastrointestinal and infectious disease, marketing Talicia for H. pylori infection and Aemcolo for travelers' diarrhea.

Developed microRNA-based diagnostic tests and pursued microRNA-targeted therapeutic programs for cancer.

Biopharmaceutical company developing IL-17-targeting NanoAb antibodies and monoclonal antibody PC111 for inflammatory and immune-mediated skin disease (including pemphigus vulgaris), plus CDMO manufacturing services; rebranded from BiondVax Pharmaceuticals, which had developed the M-001 universal flu vaccine candidate.

Clinical-stage pharmaceutical company developing cannabinoid-based drug combinations for neurological and psychiatric conditions including Tourette syndrome, Alzheimer's disease, autism spectrum disorder and chronic pain.

Develops and commercializes topical dermatological drugs, including Twyneo (acne) and Epsolay (rosacea), with SGT-610 in Phase 3 for Gorlin Syndrome.

The world's largest generic drug manufacturer, also developing and marketing branded specialty pharmaceuticals including Austedo (deutetrabenazine), Ajovy (fremanezumab) and Copaxone.

Develops AI software that assists endoscopists in detecting gastric and esophageal cancer during upper GI endoscopy in real time.

Designs and manufactures photon-counting X-ray detectors and radiation-measurement/imaging equipment used in medical and industrial CT/X-ray imaging.

Develops prescription digital therapeutics (DTx) apps for behavioral-change disease treatment, including Japan's first medical-device-approved nicotine-dependence app and a hypertension-treatment app.

Develops an ultrasound computed tomography (USCT) breast-imaging device for early breast-cancer screening without compression, developed at the University of Tokyo Entrepreneurship Lab.

Runs curon, an online medical/telepharmacy consultation platform connecting patients to doctors and pharmacists, plus MiROHA for decentralized clinical trials and electronic informed consent, and a digital-therapeutics business.

Turkish private hospital network with 29+ hospitals and 15+ medical centers, plus outpatient clinics and laboratories.

South African pharmaceutical manufacturer marketing healthcare products to both private and public sectors.

Africa's largest pharmaceutical company, manufacturing and distributing branded and generic pharmaceuticals including sterile injectables, oral solid dose, biologicals and APIs.

Brazil and Latin America's largest integrated diagnostic-medicine network, spanning labs, imaging centers, hospitals, genomics, oncology, and telemedicine.

South African financial services and private health insurance group; operator of the Vitality wellness/insurance program licensed internationally.

Brazil's largest 100%-nationally-owned pharmaceutical multinational, manufacturing and distributing medicines across 22 countries with plants in 10 Latin American nations.

Chile's largest pharmacy chain by market share, also selling perfumery and beauty products; owned by Mexican conglomerate FEMSA since 2015/2020.

Generic-drug pharmacy chain paired with attached low-cost physician clinics, sold under the 'Dr. Simi' brand and mascot, expanded into franchises across Latin America, the US and Japan.

Develops and markets over-the-counter medications and dermocosmetic personal-care products, operating in Mexico and 15+ other countries.

Diagnostic-medicine and medical-services chain, Brazil's second-largest in the sector, running labs, imaging and clinic units.

Argentine pharmaceutical/biotech holding group founded by Hugo Sigman and Silvia Gold, with pharma representing 80% of revenue; owns Chemo (APIs/generics), Exeltis (branded pharma), and biosimilars maker mAbxience, plus stakes in Elea, Biogénesis Bagó, Sinergium Biotech, and Inmunova.

Mexican conglomerate led by the Vázquez family, running the private Hospital Ángeles chain plus a pharmaceutical arm (Laboratorios Kener), financial services, media, and hotel businesses; rebranded from Grupo Empresarial Ángeles to Grupo Vazol in December 2024.

Brazil's largest vertically-integrated health-plan operator, running its own health/dental insurance plans alongside owned hospitals and clinics, formed by the 2022 merger of Hapvida and NotreDame Intermédica.

Generic and in-licensed pharmaceutical manufacturer across branded generics (MENA), injectables (US/Europe/MENA), and oral generics (US).

Largest Brazilian pharmaceutical company by market capitalization, selling pharmaceuticals, consumer-health/OTC and cosmetics products under multiple brands including Mantecorp.

AI company (founded in Tunis) building AI-driven solutions including an early-warning system for COVID-19 variant detection; post-acquisition, its platform underpins BioNTech's AI-driven drug discovery.

São Paulo state government research institute and vaccine/serum manufacturer, producing influenza, hepatitis, HPV and other vaccines plus antivenom serums for Brazil's National Immunization Program; manufactured CoronaVac locally with Sinovac during COVID-19.

Argentine multinational pharmaceutical-chemical company selling 480+ products across 46 therapeutic lines in 47 countries, with 11 production plants worldwide.

Private hospital network operating 75 healthcare facilities across South Africa, Botswana and Namibia.

International private hospital group with operations in South Africa, Namibia, Switzerland and the United Arab Emirates.

South Africa's largest private hospital network, also operating Medicross clinics and Akeso psychiatric facilities.

Latin America's largest private hospital operator, running a network of hospitals, oncology clinics, and diagnostic services across Brazil.

Colombian producer, marketer and distributor of pharmaceutical, mass-consumption and personal-care products, including the MK generics brand; roughly 14% share of the Colombian pharma market.

Corporate wellness benefits platform giving employees access to a network of gyms, studios, and fitness/mental-health/nutrition/sleep apps; rebranded from Gympass to Wellhub in 2024.

AI patient-monitoring software (AITRICS-VC / VitalCare) that analyzes real-time hospital EMR data to predict patient deterioration.

Develops biobetter platforms that convert IV biologics to subcutaneous formulations (Hybrozyme/ALT-B4 recombinant hyaluronidase) and a long-acting NexP sustained-release platform.

Was a CNS/fibrosis drug developer (BBT-877, an autotaxin inhibitor for idiopathic pulmonary fibrosis; BBT-401) before its clinical programs stalled; the KOSDAQ-listed corporate shell has since pivoted entirely to institutional bitcoin holding and mining.

Develops and manufactures biosimilar monoclonal antibodies, including Remsima (infliximab), Truxima (rituximab) and Herzuma (trastuzumab).

Cell-analysis automation instrument maker; its Laminar Wash technology automates cell-based sample-preparation workflows used across drug discovery and cell therapy manufacturing.

Develops therapeutics for metabolic disease, neurodegenerative disease, fibrosis and obesity (including GLP-1-class candidates), plus radiopharmaceuticals; parent of Neuraly.

AI-based digital pathology software (DeepDx) for detecting and grading prostate and breast cancer from tissue slide images.

Telemedicine app for non-face-to-face doctor consultations with prescription delivery to pharmacies.

Plasma-derived protein therapies, recombinant antibodies, and vaccines — developed Hepavax B (world's 3rd hepatitis B vaccine, 1983) and Hantavax (world's first hemorrhagic-fever vaccine, 1988).

Full-line pharmaceutical company with an R&D-driven pipeline; pioneered Korea's biodollar out-licensing model with a string of global deals for metabolic-disease and oncology assets.

Pharmaceutical manufacturer whose blockbuster is Ketirah/K-Cab (tegoprazan), a P-CAB gastroesophageal-reflux drug now sold in 55 countries; also active in bispecific antibody co-development (IMB-101, with Y-Biologics and IM Biologics).

Botulinum toxin (Botulax, sold in the US as Letybo) and dermal filler / skin booster / cosmetics maker — Korea's aesthetics-biologics category leader.

Long-acting injectable microsphere drug-delivery platform (IVL-DrugFluidic) developer, also working on lipid nanoparticle formulations, applied to obesity/diabetes and dementia therapeutics.

Develops antibody-cytokine fusion protein and ADC-platform immuno-oncology and autoimmune-disease drugs.

Microbiome-based therapeutics and functional probiotics developer, targeting irritable bowel syndrome and atopic dermatitis among other indications.

AI-based image analysis and functional-assessment software for coronary intervention, including angiography-derived FFR and brain-vessel analysis.

Botulinum toxin pioneer (Meditoxin, exported as Neuronox; Innotox and Coretox liquid formulations) plus Neramis HA fillers — developed the first non-animal-derived liquid botulinum toxin formulations.

Online anonymous psychological counseling platform offering voice, text and face-to-face therapy, assessments and corporate EAP services.

RNA interference (RNAi) therapeutics developer using proprietary asymmetric siRNA (asiRNA), long asiRNA (lasiRNA), and self-delivering asiRNA (cp-asiRNA) platforms.

AI-based drug-repurposing and discovery platform (RAPTOR AI), also developing an AI multi-cancer early-detection (MCED) diagnostic.

Oncology-focused new-drug developer; subsidiary of Je il Pharm Holdings (Daeeil Pharma group). Commercial product Zacubo (zastaprazan) is a P-CAB gastric-acid drug that has been out-licensed to 21 countries.

Drug developer (originally via its US subsidiary Genosco) plus functional materials and dental bone-graft businesses; co-developed lazertinib, later out-licensed onward by partner Yuhan to Janssen/J&J.

Fully human antibody therapeutics developer using phage-display and cancer-stem-cell-library platforms for oncology and ophthalmology indications.

Global contract development and manufacturing organization (CDMO) for monoclonal antibodies, bispecific antibodies, antibody-drug conjugates and mRNA vaccines.

Vaccine developer and manufacturer; developed Korea's first homegrown COVID-19 vaccine (Skycovione) and contract-manufactures AstraZeneca's and Novavax's COVID-19 vaccines.

CDMO for active pharmaceutical ingredients, specializing in oligonucleotide APIs (siRNA, ASO) and small molecules — a key player in Korea's RNA-therapeutics manufacturing capacity.

AI diagnostic software for chest X-ray, retinal fundus imaging and vital-sign-based cardiac arrest risk prediction (VUNO Med product line).

Antibody discovery and development company that both advances its own bispecific pipeline and offers antibody discovery/manufacturing as a contract research service.

Polymer/lipid hybrid nanoparticle delivery platform (ATP) for vaccines and other payloads, notably thermostable mRNA vaccines that avoid ultra-cold storage.

Pharmaceutical manufacturer and distributor (generics under the XEPA brand) with an orthopaedic-device contract-manufacturing arm (Zynexis) and distribution/logistics across Singapore and Malaysia.

Robotic-assisted transperineal prostate biopsy and ablation system (Mona Lisa platform) for prostate cancer diagnosis and treatment.

Cell-therapy company developing CAR-T, TIL and TCR-T immunotherapies for solid tumors, operating dual GMP facilities in Singapore and Guangzhou, China.

Life-science tools manufacturer (CO2 incubators, biosafety cabinets, bioreactors, IVF culture equipment) with a CRDMO arm, Esco Aster, serving cell-therapy and biopharma manufacturing.

Precision biotherapeutics company developing antibody-based cancer treatments, including ADCs, using computational and systems biology to select targets.

RNA/microRNA blood-test diagnostics company for early cancer detection, best known for the GASTROClear gastric cancer test; also NGS panels and biobanking services.

Genetic-testing company offering pharmacogenomics (RxReady, RxMax), cancer-risk, prenatal NIPT and nutrigenomics testing panels, with dual Singapore and Indonesia operations.

Genetic-medicine company developing gene therapies for cardiomyopathies using a mechanobiology-centered approach.

Cardio-pulmonary remote-monitoring platform combining wearable sensors with a decentralized clinical-trials data product (Respiree 1Bio) and a hospital-at-home/chronic-disease monitoring product (Respiree Care).

Precision oncology company offering NGS-based comprehensive and targeted genomic panels for cancer diagnosis and treatment selection, serving hospitals, physicians and biopharma partners.

Taiwan's principal domestic vaccine manufacturer, producing influenza and other vaccines and described as Asia's only vaccine maker approved by both EU GMP and US FDA.

Point-of-care diagnostics company built on semiconductor-style biosensor manufacturing, making self-monitoring blood glucose systems, home health-management devices and professional clinical testing products.

Dermatology-focused biotech developing CBL-514, an injectable small molecule for localized subcutaneous fat reduction and Dercum's disease, now in Phase 3.

Originally a pharmaceutical manufacturer, now operates as a professional biotech investment holding company that funds, restructures and incubates portfolio biotech firms; also runs an affiliated venture arm (Center Ventures / 玉晟生技創投), separately catalogued as an investor.

Oncology and neurology drug developer with implantable and injectable candidates: Cerebraca Wafer (with temozolomide) for recurrent glioblastoma, EF-009 for pancreatic cancer, and HK-001 studied in ALS.

API manufacturer and CDMO offering custom synthesis, ADC bioconjugation, injectable manufacturing, fermentation and peptide synthesis services; parent group includes SynChem-Formosa and Formosa Laboratories Japan.

Genomics/molecular-diagnostics company spanning scientific sequencing and synthesis services, clinical testing (reproductive health screening, cancer detection), and CRDMO nucleic-acid/peptide manufacturing — described as Taiwan's only company spanning both sequencing and synthesis.

CNS drug developer whose lead candidate LT3001 is in Phase 2 for acute ischemic stroke (including patients undergoing endovascular thrombectomy); also markets Naldebain injectable analgesics.

Biologics/biosimilars CDMO offering drug substance and drug product manufacturing for bispecific/multispecific antibodies, ADCs, and cell and gene therapies from two GMP plants in Miaoli.

Cancer-focused biotech developing antibody-drug conjugates and cancer immunotherapies, including a TROP2-targeted ADC and a triple-negative breast cancer immunotherapy.

Developer of BESREMi (ropeginterferon alfa-2b), an engineered long-acting interferon for polycythemia vera and essential thrombocythemia, commercialized in the US, Europe, Japan and Korea.

API/CDMO manufacturer specializing in active pharmaceutical ingredients for oncology and other complex generic and branded drugs, headquartered in the Southern Taiwan Science Park.

Contact lens manufacturer — Taiwan's largest and the world's fifth-largest — selling under its own TICON brand plus OEM/ODM for global customers.

Regenerative-medicine company developing Stemchymal, an allogeneic mesenchymal stem cell therapy for polyglutamine spinocerebellar ataxia, also studied in osteoarthritis and liver failure.

In vitro diagnostics and vital-signs device manufacturer making blood glucose monitors, blood pressure monitors, thermometers and IVD devices; became a major producer of COVID-19 rapid antigen test kits.

Small-molecule drug developer focused on anti-infection therapeutics, marketing the antibiotic nemonoxacin (Taigexyn) and developing an influenza antiviral and other NCE programs.

Develops long-acting biologic drugs for HIV; its lead product ibalizumab (Trogarzo) is an anti-CD4 monoclonal antibody for multidrug-resistant HIV-1, and it also researches an HIV vaccine with the Gates Foundation.

Oncology drug developer advancing CVM-1118 (in combination with sorafenib and nivolumab) for hepatocellular carcinoma and neuroendocrine tumors, plus TRX-818 and TRX-920 for solid tumors.

Drug developer focused on liver disease, with lead candidate JKB-122 tested across chronic hepatitis C, autoimmune hepatitis and NASH with fibrosis.

Biosimilars developer; ran completed Phase 3 trials for TX05, a trastuzumab (Herceptin) biosimilar, in HER2-positive early breast cancer with neoadjuvant/adjuvant treatment.

Designs and manufactures single-cell and spatial-omics sequencing instruments and reagent kits for life-science research.

Direct-to-consumer genetic testing service analyzing saliva samples via SNP genotyping to report ancestry and genetic health-predisposition information.

Generative AI platform for clinical conversations — ambient documentation spanning pre-visit prep through post-visit follow-up, plus tailored products for revenue-cycle management and nursing staff, used by 300+ health systems.

Develops, manufactures, and sells image-guided radiation therapy systems — the CyberKnife and TomoTherapy platforms (including the Radixact System) — for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).

Immune-medicine platform that reads and translates the adaptive immune system at scale (immunosequencing) for both diagnostics — e.g. the clonoSEQ minimal-residual-disease test — and drug discovery.

Builds and manages accountable care organizations (ACOs) that help independent primary-care practices take on and succeed in value-based, risk-sharing contracts with Medicare, Medicaid, and commercial payers.

Developer of allogeneic (off-the-shelf) CAR T-cell therapies (AlloCAR T) for cancer, in contrast to patient-specific autologous CAR-T.

Discovers, develops and commercializes RNA interference (RNAi) therapeutics for genetically defined diseases.

Develops induced pluripotent stem cell-based cellular rejuvenation therapies intended to restore cell health and resilience.

AI platform for clinical documentation and medical coding that integrates directly into Epic and other EHRs, covering 200+ medical specialties across ambulatory, ED, and inpatient settings.

Blood-based early cancer detection company using biomarker and multi-omic approaches, focused first on ovarian cancer.

Targeted protein degradation (PROTAC) company; developed vepdegestrant, an oral estrogen receptor degrader for breast cancer, partnered with Pfizer, and luxdegalutamide, an androgen receptor degrader partnered with Novartis.

Biotechnology company researching CRISPR base editing and prime editing for gene therapies.

Developer of the Butterfly iQ, a handheld point-of-care ultrasound device using proprietary Ultrasound-on-Chip silicon technology that connects to a smartphone.

Molecular diagnostics company that automates nucleic-acid testing for pathogen and genetic-disorder identification; its GeneXpert system performs automated, point-of-care real-time PCR testing.

Developed novel small-molecule therapies for neurological and psychiatric illnesses, spun out of Pfizer's neuroscience pipeline with Bain Capital.

Biosimulation and model-informed drug-development software and services used across preclinical research, clinical trials and regulatory submissions.

Contract research organization (CRO) providing preclinical and clinical laboratory services — toxicology, safety testing and research models — for drug, vaccine and medical-device development.

Value-based primary, behavioral, and social care provider for Medicaid and low-income Medicare members, delivered by community-based care teams and a member app; spun out of Alphabet's Sidewalk Labs.

Developer of precision T-cell engagers (pHLAre molecules) that target mutated protein fragments displayed on cancer cells (e.g. KRAS, p53) while sparing healthy tissue.

Protein-engineering company whose CodeEvolver platform designs enzymes used in pharmaceutical, RNAi therapeutics manufacturing, food and other industrial applications.

Developer of non-hormonal male contraceptive technologies, including the ADAM implant and the NES/T daily topical gel.

Developer of the CorPath robotic system, which uses remote control and robotics to manipulate coronary guidewires and balloon/stent catheters for image-guided vascular intervention.

Vertically integrated Medicare Advantage health plan for older Americans that combines senior-focused insurance with its own virtual and in-home primary-care service, Devoted Medical.

Maker of continuous glucose monitoring (CGM) systems for diabetes management, including the G-series (G6, G7) wearable sensors.

Dispatches clinical teams to deliver hospital-level, high-acuity medical care in patients' homes (ER-alternative visits, hospital-at-home, skilled nursing facility alternative); merged with Medically Home in 2025 to form a combined national at-home care platform under the DispatchHealth name.

Develops bispecific 'proximity engager' antibody therapies; lead candidate DTX-102 pairs an anti-CD28 arm with an immune proximity engager for rheumatoid arthritis.

Maker of the WiSE System, a leadless left-ventricular endocardial pacing device that enables cardiac resynchronization therapy without transvenous leads.

Develops therapies for rare and other diseases based on CRISPR gene editing technology.

Molecular diagnostics company focused on early cancer detection; developer of Cologuard, the first stool-DNA test for colorectal cancer screening.

Wireless wearable fitness technology — smartwatches, activity trackers, pedometers and heart-rate monitors — with companion software and mobile apps.

Develops, manufactures, and sells genomic profiling assays based on next-generation sequencing for solid tumors, hematologic malignancies, and sarcomas, marketed as companion diagnostics (e.g. FoundationOne CDx).

AI medical scribe and front-desk platform for independent clinics — converts patient conversations into clinical notes, suggests medical codes, and offers an AI receptionist.

Membership-based, direct-to-consumer whole-body diagnostics platform running ~160 blood/urine biomarker tests with AI-generated reports and supplement/lifestyle recommendations.

Genomic diagnostics company focused on whole-genome and whole-exome sequencing for the diagnosis of rare and inherited disorders, including in pediatric and newborn populations.

Synthetic-biology foundry that engineers custom organisms (cells, enzymes, DNA) as a platform service for other biotech, industrial and pharma companies.

Develops the Galleri multi-cancer early detection (MCED) blood test that screens for evidence of multiple cancer types from a single blood draw.

Platform that helps independent mental-health therapists start and grow their own practices while giving patients insurance-covered access to therapy and measurement-based care tools.

Precision-oncology company whose liquid-biopsy blood tests detect cancer-related mutations for screening, treatment selection and monitoring.

Direct-to-consumer telehealth and personal-care company selling prescription and over-the-counter medications and wellness products via subscription, with an in-house virtual-care clinician network.

Digital musculoskeletal (MSK) care platform offering app-based exercise therapy, wearable motion sensors, and clinical coaching for back, joint, and muscle pain; listed on the NYSE in 2025.

Builds clinically-safe generative-AI agents for healthcare — patient-facing voice agents (chronic-care check-ins, pre/post-op calls, staffing-gap coverage) and an 'AI agent app store' for health systems.

Developer of the Swoop system, described as the world's first portable MRI scanner, transportable between patients and running on a standard electrical outlet at a fraction of the cost of traditional MRI.

Healthcare AI company offering an agentic AI platform that unifies clinical, operational, and financial data across health systems, payers, and government agencies for population health, revenue cycle, and patient engagement use cases.

Maker of the Omnipod tubeless, wearable insulin patch-pump system for automated insulin delivery.

Developer of bioabsorbable, steroid-eluting sinus stents (PROPEL family) for ENT treatment of chronic sinusitis; acquired by Medtronic in 2022.

Develops, manufactures, and markets robotic surgical systems for minimally invasive surgery, most notably the da Vinci Surgical System.

Genetic testing company that offered large-scale hereditary and rare-disease genetic testing services before filing for bankruptcy.

Developed CAR-T cell immunotherapies for cancer, co-founded by Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, and Seattle Children's Research Institute.

Develops cancer immunotherapy products, primarily genetically engineered autologous CAR T-cell therapy.

Targeted protein degradation company developing oral small-molecule degraders for immunology and inflammation, partnered with Sanofi and Gilead.

Outpatient behavioral-health services provider offering therapy, psychiatry, TMS and ketamine-assisted psychotherapy in-person and via telehealth.

Value-based care company that places 'Health Navigators' inside independent rural primary-care clinics to coordinate care, close preventive-care gaps, and take on risk-based Medicare Advantage and other value-based contracts exclusively for rural America.

Developed the RIO (Robotic Arm Interactive Orthopedic System) for robotic-arm-assisted partial knee and hip orthopedic surgery.

Maker of pulse-oximetry and multi-parameter patient-monitoring devices and sensors for hospital and home settings, using Signal Extraction Technology (SET); expanded into consumer health-tracking hardware before divesting its consumer audio division.

Virtual clinic for women's and family health providing telehealth-based maternity, fertility, parenting, and menopause care, sold primarily as an employer/health-plan benefit.

Focuses on RNA therapeutics, primarily mRNA vaccines and, increasingly, mRNA-based therapeutics.

Developer of the Maestro Surgical Robotic System, a collaborative laparoscopic surgical robot, plus ScoPilot, an AI-enhanced intraoperative assistance capability.

Clinical genetic-testing company built on cell-free DNA (cfDNA) technology, serving women's health, oncology and organ-health testing.

Maker of Yomi, the first FDA-cleared robotic system for dental implant surgery, providing preoperative planning and intraoperative robotic guidance.

Small-molecule drug discovery company built around computational structure-based design for highly selective targets across oncology, immunology and metabolic disease; sold two clinical-stage programs to Big Pharma (Gilead 2016, Takeda 2023) while advancing its own pipeline.

Virtual-first chronic-disease management company delivering digital care programs (coaching, connected devices, clinical support) for prediabetes, diabetes, hypertension, high cholesterol, and musculoskeletal conditions.

Membership-based primary care provider combining in-person clinics with a mobile app and 24/7 virtual care; went public on Nasdaq in 2020 and is now operated as a subsidiary of Amazon.

Technology-driven health insurance company offering individual, small-group, and Medicare Advantage plans through a consumer-facing digital member experience.

AI-powered digital pathology platform (AISight Dx) for enterprise pathology labs, plus AI diagnostic tools such as PathAssist Derm (dermatopathology) and AIM-MASH (liver disease clinical trials).

Cancer genomics company offering NeXT Personal, a tumor-informed liquid-biopsy test for minimal-residual-disease detection and monitoring, and ImmunoID NeXT tissue profiling.

Mobile cardiac health company that made the BodyGuardian remote ECG/vitals monitoring system for ambulatory cardiac monitoring.

Biotechnology company developing gene-editing therapies based on prime editing.

Enterprise generative-AI platform built for health systems — centralizes AI workflows, pre-validated clinical/operational solutions, EHR data connections, an agent-builder toolkit, and governance/oversight for AI deployed in care settings.

AI-driven drug discovery company that maps biology at scale to generate and prioritize drug candidates, with a pipeline spanning oncology and rare disease.

Developer of neurovascular intervention devices for stroke treatment, including the FreeClimb catheter system and the investigational HiPoint Reperfusion System.

Engineers cells as medicines — repairing/controlling genes in cells or replacing missing/damaged cells — with programs spanning type 1 diabetes, B-cell cancers, and B-cell autoimmune disorders.

Computational platform (physics-based simulation plus ML) for molecular design, licensed to pharma/biotech/materials companies and also used to advance Schrödinger's own drug pipeline.

Proteomics company whose Proteograph platform uses engineered nanoparticles to enable deep, unbiased protein profiling from biological samples.

Maker of the Eversense implantable continuous glucose monitor (CGM) -- the only long-duration implantable CGM on the market, most recently the one-year Eversense 365.

Pioneered microbiome therapeutics, developing defined bacterial-consortia drugs.

Runs 'Bioforge' biomanufacturing plants that combine enzymatic and chemical processes to make bio-based specialty chemicals as sustainable replacements for petroleum-derived products.

Full-stack, value-based kidney care company that partners with health plans and providers to manage patients with or at risk of chronic kidney disease using its RenalIQ analytics platform and field-based care teams.

Developer of AAV gene therapy treatments for debilitating genetic diseases.

Makes robotic magnetic navigation systems used by physicians to perform minimally invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation.

Maker of the t:slim X2 touchscreen insulin pump and automated insulin delivery systems, interoperable with Dexcom CGM.

Uses genomic sequencing and AI to power precision-medicine diagnostics across oncology, cardiology, radiology and mental health.

Value-based oncology care company providing 24/7 cancer-care navigation and coordination between patients, oncologists, and payers through its Thyme Care Connect and Thyme Care Signal platforms.

AI-powered health and care navigation platform ('WayFinding') that self-insured employers and health plans offer members as a single place to access benefits, care navigation, and specialty care (cancer, surgery, weight health).

Developer of T-cell receptor-engineered T-cell (TCR-T) therapies for hematologic and solid cancers, and TCR-directed therapies for autoimmunity.

Manufactures synthetic DNA and DNA-based products (including for biopharma R&D and synthetic biology applications) using a silicon-based synthesis platform.

Develops in vivo base-editing (CRISPR) gene therapies targeting PCSK9 to durably lower LDL cholesterol.

AI-powered digital therapeutics platform (BlueStar) for cardiometabolic chronic-disease management, covering diabetes, hypertension, weight management and other conditions, with EHR and payer integrations.

Vertically integrated, clinical-stage radiopharmaceutical company developing targeted alpha therapies (lead isotope Pb-212) for cancer, led by ADVC001 in prostate cancer.

Designs and supplies integrated, all-in-one rapid diagnostic test devices (AtomoRapid platform) for blood-based point-of-care testing, including the Atomo HIV Self Test.

Clinical-stage radiopharmaceutical company developing copper-64/67 theranostic products for cancer, led by SAR-bisPSMA for prostate cancer imaging/therapy and SAR-Bombesin for breast, ovarian and lung cancers.

Makes point-of-care weight-bearing medical imaging systems for musculoskeletal extremities — HiRise (bilateral weight-bearing CT), LineUP (knee/lower extremity), pedCAT (foot/ankle) and InReach (extremity CT).

Clinical-stage biopharmaceutical company with a portfolio of drug candidates for inflammatory diseases, including kidney and respiratory conditions.

Genetic testing company offering reproductive carrier screening (cystic fibrosis, SMA, fragile X) and preventative health screening across 180+ genes linked to inherited cancer, heart disease and metabolic risk.

AI-automated 3D pre-operative planning software for joint-replacement surgery, converting medical scans into interactive 3D models for patient-specific implant selection and placement; flagship product Formus Hip.

Builds clinical AI models that read medical images (chest X-ray, CT brain, CT chest) to flag findings for radiologists in seconds, deployed across more than 1,000 clinical sites.

24/7 Australian telehealth platform for online doctor consultations, prescription delivery, pathology referrals, medical certificates and specialist referrals.

New Zealand medtech company whose femfit pelvic-floor training system pairs a pressure-sensor intravaginal device with a mobile app to treat female urinary incontinence.

Implantable pressure sensor that continuously monitors cerebrospinal-fluid dynamics for hydrocephalus patients, giving patients and clinicians real-time data as an alternative to unchanged 1950s-era shunt systems.

Develops and manufactures point-of-care diagnostics for infectious disease, led by FebriDx (differentiates viral vs bacterial respiratory infection from a fingerstick sample) and ViraDx (flu A/B and COVID-19); also runs assay development/manufacturing services.

Clinical practice management software for general practices and specialist surgeries — cloud (Helix) and desktop (Clinical, Pracsoft, Bluechip, Day Surgery) products handling patient records, billing and scheduling.

AI-powered digital-therapeutic apps that train the brain-body axis via validated behavioral programs, spanning IBS (Nerva), menopause (Evia), mental health (Claria) and chronic pain (Relio).

Biopharmaceutical company treating rare neurodevelopmental disorders; commercializes DAYBUE (trofinetide) for Rett syndrome (with US partner Acadia Pharmaceuticals) and is developing NNZ-2591 for Phelan-McDermid, Angelman and Pitt Hopkins syndromes.

Develops Cxbladder, a suite of non-invasive, urine-based genomic biomarker tests for ruling out and monitoring bladder cancer, run out of ISO15189 labs in New Zealand and CLIA/CAP/NYS-certified labs in the US.

Digital health engagement platform using behavioural science, gamification and clinical measurement to improve treatment adherence for underserved patient populations across 25+ health conditions.

Developer of biodegradable polymer implants (PREZIA platform) for sustained ophthalmic drug delivery, initially targeting glaucoma.

Healthcare software for hospital costing, revenue-cycle management, enterprise billing, patient safety, budgeting and wayfinding, sold to state health departments and district health boards.

Healthcare-imaging informatics company supplying radiology information systems (RIS) and the Visage 7 enterprise imaging/PACS platform to hospitals and imaging centres in Australia, North America and Europe.

Clinical-stage RNA therapeutics company using cell-penetrating peptides to deliver oligonucleotide drugs for genetic diseases, with programs in retinitis pigmentosa, optic atrophy, Phelan-McDermid syndrome and polycystic kidney disease.

Built AI software for ultrasound reporting — automatically analyzing thyroid and breast ultrasound images to generate structured radiology reports using ACR TI-RADS and BI-RADS criteria.

Employee-wellbeing app combining 24/7 mental-health counselling, telehealth medical support (nurses/GPs) and personal-safety tools (journey tracking, critical-incident response) in a single platform for employers.

Commercial-stage radiopharmaceutical company developing diagnostic and therapeutic agents for cancer, spanning Precision Medicine, Therapeutics and Manufacturing Solutions divisions.

AI models that read retinal photographs to screen for systemic disease risk — BioAge (biological-age assessment), CLAiR (cardiovascular risk) and MyKidneyAI (chronic kidney disease detection in diabetics) — built on a dataset of 4.3M+ retinal images.

Develops Axana, a portable AI-enhanced magnetic resonance brain scanner meant to bring stroke imaging to the point of care and cut diagnostic delay in the acute 'golden hour'.

Makes a robotic patient-transfer device that helps hospital staff safely move patients, addressing workforce shortages.

Virtual care platform combining an on-demand healthcare app with a tech-enabled in-person clinic (Union Health) aimed at reducing strain on Canada's healthcare system.

Cloud-based home and community care software platform used by home-care agencies for scheduling, clinical documentation, remote patient monitoring, and billing.

Clinical-stage precision-oncology company developing tuspetinib-based combination therapy for acute myeloid leukemia.

Orthopedic-trauma surgical device maker whose TrakPak skeletal traction system and sterile-packed drill kits (built with DEWALT) simplify procedures and cut costs for hospitals worldwide.

Bioprinted-tissue-therapeutics company designing implantable, 3D-bioprinted living tissues to replace, repair or supplement biological function, including for type 1 diabetes.

Biopharmaceutical company delivering therapies for autoimmune diseases with high unmet medical need.

Developed camlipixant, a selective P2X3 antagonist for refractory chronic cough.

Infectious disease intelligence company combining AI with expert epidemiological analysis to deliver outbreak alerts, risk assessments, and surveillance of 190+ diseases; used by governments including Canada during COVID-19.

Health data infrastructure company whose Context Engine turns fragmented health records into a unified, agent-ready patient view for AI systems and clinical workflows.

Develops custom 3D-printed gynecological prosthetics to treat pelvic floor disorders.

Clinical-stage pharmaceutical company developing proprietary deuterated psilocybin- and DMT-analog serotonergic agonists for depression, anxiety and other mental-health conditions.

AI-powered therapeutics company using machine learning to discover and develop genetic-medicine drug candidates.

University of Alberta spinout operating a drug and drug-interaction data platform/API used across the pharmaceutical and clinical-decision-support ecosystem.

Developing an at-home hormone testing/monitoring device for reproductive and metabolic health.

Wearable medical device designed to improve functional vision for people with low vision or legal blindness.

Develops high-resolution micro-ultrasound systems (ExactVu) for real-time prostate imaging and biopsy guidance.

Clinical-stage biopharmaceutical company developing peripherally-restricted CB1 receptor modulators for obesity, metabolic and fibrotic diseases.

Virtual care platform connecting Canadians with doctors, nurse practitioners and specialists for online consultations, prescriptions, lab requisitions and medical notes.

Commercial-stage biopharmaceutical company developing self-administered cardiovascular therapies.

Makes MIMOSA Pro, a pocket-sized near-infrared imaging device that non-invasively assesses tissue oxygenation and temperature at the point of care for wound care, peripheral vascular disease, and burn assessment.

Acquires and operates a network of community pharmacies across Canada under their original local banner names, providing centralized back-office support while preserving local pharmacist-led identity, with a focus on strengthening rural pharmacy access.

Makes benchtop surface plasmon resonance (SPR) biosensor instruments that make protein-interaction testing more accessible to researchers.

Makes biophysical characterization instruments — including the OpenSPR surface plasmon resonance platform — that measure molecular binding kinetics for life-science researchers.

Proteomics-as-a-service platform (nELISA technology, Omni 1000 assay) offering affordable, absolute quantification of 1,000 informative proteins per sample.

AI-powered retinal imaging platform for early, non-invasive detection of Alzheimer's disease.

Big-data warehouse platform providing privacy, security, and governance controls for organizations (including healthcare payers/providers) mining sensitive data at scale.

Full-service digital pharmacy that delivers prescription medication directly to patients across Canada.

Develops MRI-guided, robotically driven, incisionless ablation systems — TULSA-PRO for prostate tissue and Sonalleve for bone/soft-tissue pain palliation.

Clinical-stage biotechnology company developing antibody therapeutics and vaccines that target toxic misfolded proteins in neurodegenerative diseases.

Designs and manufactures a miniaturized, automated radiopharmaceutical synthesis platform — a shielded synthesizer using disposable microfluidic chips for end-to-end chemical and radiochemical reactions in research and clinical settings.

Clinical AI platform that monitors hospital AI model performance and deploys predictive tools; adopted by New York's Mount Sinai Health System and Ontario's Grand River Hospital.

Developer of intratumorally injected 'nanofilament' immunotherapy designed to boost tumor visibility to the immune system and restore antitumor immune responses.

Biopharmaceutical company that developed and marketed therapies for people living with HIV, including a tesamorelin formulation for HIV-associated lipodystrophy.

Makes the tremoflo Airwave Oscillometry System, a respiratory diagnostics device used in clinical care and clinical trials.

Developer of clinician-designed technology for cardiopulmonary bypass, addressing unmet needs for surgeons and perfusionists caring for patients on bypass.

Digital mental health platform for Canadians offering online therapy programs.

AI-powered medical record review platform that automates document analysis for insurance organizations.

Neuroscience-focused biopharmaceutical company developing ion-channel-targeted drugs for epilepsy, depression, bipolar depression and pain.

Clinical-stage biopharma developing ABTL0812, a first-in-class autophagy-inducing therapeutic, currently in Phase 2b for metastatic pancreatic cancer after completing Phase 2a in endometrial and lung cancer.

Clinical-stage biotech developing therapies that modulate the immune response in chronic inflammatory diseases.

Nanobody (single-domain antibody fragment) therapeutics company; lead product caplacizumab (Cablivi) treats a rare blood-clotting disorder.

Commercial-stage oncology company specializing in antibody-drug conjugates (ADCs).

Develops a new generation of antibody-drug conjugates (ADCs) engineered to address cancers with high unmet medical need.

Develops next-generation radiopharmaceuticals and immunology therapeutics based on the proprietary Affibody molecule protein-engineering platform.

Deep-learning AI platform for pathology image analysis, used by pathologists and scientists in clinical, pre-clinical and academic labs, including cancer-specific AI suites (breast, lung, prostate, gastric).

Digitally-native health insurer combining complementary health coverage, care access and prevention, licensed as an insurer in France and operating in Belgium, Spain and Canada.

Analyses patient antibody repertoires to identify naturally protective antibodies and develop them as antibody therapeutics for neurodegenerative disease and oncology.

Clinical-stage biotechnology company developing antibody-based pharmaceuticals for cancer treatment, focused on tumor-directed agonistic mono- and bispecific antibodies.

Develops and manufactures biosimilars, cost-competitive versions of biologic medicines, to make proven biologic treatments more accessible globally.

Precision-healthcare company offering at-home polygenic risk score (PRS) genetic tests for breast, prostate, colorectal cancer and melanoma, paired with personalized prevention plans.

Develops antibody-drug conjugates (ADCs) using a proprietary peptide-linker platform that attaches cytotoxic payloads to off-the-shelf antibodies without re-engineering them.

Immunology biotech developing antibody therapies for autoimmune diseases and cancer; lead product Vyvgart treats myasthenia gravis.

Develops small-molecule DNA damage response (DDR) inhibitors for oncology.

Builds LINQ, a modular, AI-ready lab-automation robotics platform with node-based workflow design software for life-science labs.

AI-driven virtual primary care service that connected patients to clinicians via app-based chat, video consultations and a symptom checker, at one point serving both NHS GP-at-hand patients and US Medicaid/Medicare Advantage populations.

Detects cancer earlier using precision DNA-methylation sequencing.

Builds an AI/machine-learning knowledge-graph platform ('life science intelligence') to guide pharmaceutical target identification and drug R&D decisions.

Developer of monolithic chromatography columns and bioprocessing/analytical platforms for purifying large biomolecules (pDNA, mRNA, LNPs, AAV, lentivirus) used in gene-therapy and vaccine manufacturing.

Family-owned R&D pharma focused primarily on Parkinson's disease and epilepsy treatments; does not sell products directly to consumers.

Develops Bicycle® bicyclic peptide drugs — a modality combining antibody-like target precision with the manufacturability of synthetic chemistry — mainly for oncology.

Molecular diagnostics company built around the Idylla platform, a fully automated real-time PCR system for oncology biomarker testing.

Manufacturer of in-vitro diagnostic reagents for histopathology, cytology, hematology and microbiology, plus rapid immunochromatographic tests.

Clinical-stage biopharmaceutical company developing antibacterial therapies against antimicrobial resistance, including ESKAPE-pathogen and tuberculosis programs.

All-in-one software platform for UK home-care agencies covering care management, rostering, billing/finance, quality & compliance and workforce engagement, used by 1,000+ homecare businesses.

Synthetic biology company that reprograms induced pluripotent stem cells (iPSCs) into defined human cell types using its patented opti-ox safe-harbour gene-targeting technology, for research, drug discovery and cell therapy.

Genetic testing company for inherited diseases, offering diagnostic panels across 14 medical specialties, whole-exome sequencing, single-gene and variant-specific tests.

Oxford University spinout building AI imaging-analysis software for stroke (Brainomix 360 Stroke) and lung disease (e-Lung), interpreting CT/MRI scans in real time to speed treatment decisions.

Drug discovery company using its Conformetrix 4D structural-design and PatientSeek genetic-stratification platforms to design small-molecule medicines for immuno-inflammatory disease.

Developer of Aeson, a bioprosthetic total artificial heart for patients with end-stage biventricular heart failure.

Clinical trial data platform offering electronic data capture (EDC), eCOA/ePRO, eConsent and AI-assisted data extraction for biotech, medical-device and academic researchers.

Clinical-stage immuno-oncology company targeting GDF-15, a key cancer-therapy resistance mechanism, to reinstate anti-tumor immune-cell activation and tumor infiltration.

AI-powered home-care platform matching people needing in-home assistance with professional carers, and providing families with progress updates; describes itself as the UK's largest healthtech company.

AI software (Apollo) that detects critical conditions (infarcts, intracranial hemorrhages, tumors) in real time during brain MRI acquisition, prioritizing urgent cases for radiologist review.

All-in-one clinical research software platform offering electronic data capture (EDC), patient-reported outcomes (eCOA/ePRO), and hybrid/decentralized clinical trial capabilities for pharma, medtech, CRO and academic customers.

Developer of Versius, a modular, portable soft-tissue surgical robot competing with Intuitive's da Vinci system.

Develops cNeuro AI software that analyzes MRI, PET and other neuroimaging data to support clinical decision-making in dementia and other neurological disorders.

Drug-discovery biotech using proprietary GPCR-stabilizing technology to design small-molecule and antibody therapies for metabolic and endocrine diseases.

Clinical genomic interpretation platform (spun out of the Wellcome Sanger Institute) that turns sequencing data into actionable variant reports for rare disease, oncology and infectious-disease labs.

Clinical-grade AI platform for healthcare covering medical speech-to-text, ambient documentation, automated medical coding, and an agentic framework, originally built for emergency-call triage.

AI-enabled remote patient monitoring and clinical-oversight infrastructure that lets hospitals deliver advanced therapies (CAR-T, cell and gene therapy, high-acuity care) in the home.

Late-stage clinical biotech producing denovoSkin, an autologous, lab-grown living human skin graft for burns and reconstructive/aesthetic skin surgery, manufactured on a proprietary automated platform at a GMP-certified facility in Zurich.

Precision oncology drug-discovery company exploiting novel synthetic-lethal ('Achilles heel') dependencies in cancer, working with leading academic partners.

Epicutaneous immunotherapy platform (Viaskin) that desensitizes patients to food allergens such as peanut and cow's milk via a skin patch.

Privately-held Swiss biopharmaceutical company that in-licenses drug candidates and develops them through clinical testing for commercialization by pharma partners.

AI-enabled digital pathology network combining machine learning with a global network of expert pathologists for faster diagnostics; operates NHS-focused clinical brand Diagnexia and pharma-research brand Patholytix, with digital accessioning centers in the US, UK, Canada and Switzerland.

Develops UllCORE BSI, a rapid molecular diagnostic test that identifies bloodstream-infection pathogens and antibiotic-resistance markers directly from blood in about one hour.

Develops allergen immunotherapy (AIT) products using recombinant allergens specifically modified to suppress histamine release during desensitization.

AI-driven automated insulin delivery system (DBLG1) that integrates with insulin pumps for Type 1 diabetes management.

Engineers next-generation antibody therapeutics for inflammatory disease using a proprietary discovery platform.

Imperial College London spinout combining a DNA test with a barcode-scanning app to give personalized food/product recommendations; pivoted during the pandemic to build the COVID Nudge rapid RT-PCR test, of which the UK government ordered thousands of units.

Virtual ward and remote-monitoring provider combining software, connected medical devices, an app and last-mile logistics with an in-house CQC-registered clinical team, serving health systems across the UK, Ireland and Europe.

Doctor-search and appointment-booking marketplace; the Polish arm (ZnanyLekarz) lists 146,000+ doctors and is part of the pan-European/Latin American Docplanner Group.

Online medical appointment booking and practice-management platform for patients and healthcare professionals, operating in France, Germany, Italy and the Netherlands.

Consumer electronics and assistive-technology company making senior-friendly phones and smartphones with large keys, accessibility features and emergency alert buttons.

Small-molecule therapeutics company using its DUNAD targeted protein degradation technology.

Develops soloMER dual-acting antibody-drug conjugates (VNAR-based biologics combining biologic precision with localised small-molecule activity) for immune-mediated inflammatory disease.

Femtech hardware maker best known for the Elvie Pump, a silent wearable breast pump that connects to a companion app; also made pelvic-floor trainers.

Develops small-molecule targeted-protein-degradation therapies acting on the Sec61 translocon, initially for immuno-inflammatory disorders; originated from Institut Pasteur research and built by Argobio Studio.

Clinical-stage microbiome therapeutics company developing EBX-102-02, an orally delivered full-spectrum microbiome drug for irritable bowel syndrome and other GI/liver diseases.

Global testing and laboratory-services group serving pharma, food, environmental and consumer-products industries, including clinical diagnostic testing and in-vitro diagnostic products.

AI-driven vaccine discovery company that harnesses artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious disease.

Develops treatments for acute organ trauma, vascular damage and cancer immunotherapy.

Biopharmaceutical company that discovered filgotinib (Jyseleca), a JAK1 inhibitor for rheumatoid arthritis and Crohn's disease, and holds a major R&D collaboration with Gilead Sciences.

Gene-therapy company developing immune-shielded lentiviral vectors ('Vettori Lentivirali Immune-Shielded') aiming to widen access to gene therapy for children with genetic diseases.

Antibody-engineering biotechnology company developing fully human antibodies for cancer and autoimmune disease using proprietary platforms like DuoBody and UniBody.

Gene-therapy company developing Lumevoq (lenadogene nolparvovec), an intravitreal AAV gene therapy for Leber hereditary optic neuropathy (LHON).

Develops immunomodulating therapies using antibody-cleaving enzyme technology (imlifidase and HNSA-5487) for rare immunologic diseases including transplant desensitization.

Connected "Injection Care Management System" — a smart sharps bin plus companion app — that tracks injectable-medication use and sends adherence reminders to patients and caregivers.

TechBio company building an AI-driven, human-biology-based drug-discovery platform focused on heart failure.

Clinical-stage biotechnology company developing neurorestorative therapies aimed at slowing or stopping the progression of Parkinson's disease.

Remote patient monitoring and clinical-trial digital platform ("operating system for AI in regulated industries") spanning population health, decentralized trials and virtual care, used across health systems and life-sciences partners in 70+ countries.

AI-powered cardiology platform ('Willem') that analyzes ECG data to detect 22 cardiac patterns/arrhythmias for arrhythmia screening, pharma cardiotoxicity monitoring, and remote patient screening.

Develops immunotherapeutic antibodies targeting butyrophilin (BTN) and BTN-like (BTNL) checkpoint molecules to activate gamma-delta T cells against cancer, infectious and autoimmune disease; lead candidate ICT01 is in first-line AML trials.

Biopharmaceutical company applying proprietary anti-C5a and C5aR inhibitors to treat life-threatening or debilitating inflammatory diseases.

Immuno-oncology biotech developing NK-cell and antibody therapies for cancer; lead assets licensed to AstraZeneca and Sanofi.

Digital multimodal-therapy programs (exercise + mind-body support) for back, joint and chronic pain, and for COPD.

Digital-health app supporting pregnant women and new mothers with a pregnancy tracker, birth-preparation courses, midwife search and postpartum classes.

AI software for breast-cancer screening; its flagship product Mia (Mammography Intelligent Assessment) supported radiologists in mammography review.

Clinical-stage biotech developing inhaled cell-signal-transduction modulators for respiratory diseases.

Developer of the Gammabody bispecific gamma-delta T-cell engager platform, activating Vγ9Vδ2 T cells to target and kill cancer cells while triggering broader immune responses.

Develops small-molecule somatic-expansion inhibitors for Huntington's disease and other triplet-repeat expansion diseases.

CDMO providing end-to-end biosimilar development and manufacturing services, from gene sequence to final vialed product, including cell-line development and process/tech-transfer.

Long-acting injectable drug-delivery platform (BEPO) partnered with pharma companies; lead product Uzedy is an FDA-approved risperidone injectable for schizophrenia commercialized by Teva.

Clinical-stage vaccine developer whose lead candidate, a Group B Streptococcus vaccine (AlpN GBS), targets pregnant women and older adults to prevent adverse pregnancy outcomes and life-threatening GBS infections.

Immunology biotech developing agonist antibodies that restore natural immune checkpoints to switch off autoimmunity.

Women's-health pharma developing estetrol-based products, including the contraceptive pill Estelle (Nextstellis) and menopause treatment Donesta.

Spatial biology company whose platform maps high-plex cell-cell interactions between receptors and ligands directly within tissue, providing functional proteomics data at scale for disease-pathway research.

Platform connecting patients, physicians and pharmaceutical companies to expand access to clinical trials and investigational (pre-approval) medicines.

Nanomedicine company developing NBTXR3 (Hensify), a nanoparticle radioenhancer injected into tumors to boost the effect of radiotherapy.

Develops nanoparticle-based drug formulation technology (nanoforming) to improve the performance and delivery of small- and large-molecule drugs.

Makes the AV1 telepresence robot that lets chronically ill or isolated children attend school remotely, and the KOMP simplified communication device for elderly users.

CDMO for protein-based biologics and gene therapies, offering end-to-end development and cGMP manufacturing from preclinical through commercial scale.

Global pharmaceutical company manufacturing and marketing diabetes and obesity medications and devices, best known for the GLP-1 drug semaglutide.

Uses genomics and functional genomics of the non-coding genome to identify novel drug targets and design new medicines.

Biopharmaceutical company developing eye-drop and small-molecule therapies for neuro-ophthalmic and ophthalmic conditions.

Uses native mass spectrometry to make 'undruggable' membrane-protein and multi-protein-complex targets druggable with small molecules.

Develops targeted radiotherapeutics for peritoneal cancers, including a Phase 2 program in ovarian cancer; combined in 2025 with former AXL-kinase-inhibitor developer BerGenBio.

Develops cancer therapies for difficult-to-treat hematological cancers, centered on Peptide Drug Conjugate (PDC) technology.

AstraZeneca spin-out building a connected 'Dosage Manager' that replaces pills with an adjustable, personalized medication-dosing device.

Digital health provider for weight-related conditions — a medical-device-certified app combined with clinical teams of doctors, dietitians and behavioral specialists, treating obesity, hypertension and type 2 diabetes.

AI platform (K Pro) that works alongside pharma research teams on drug discovery, using multimodal patient data and federated learning.

Workforce-management software for the NHS covering rostering, temporary staffing bank management, job planning and appraisals, built by two NHS doctors.

Employer-funded specialist healthcare benefit app delivering clinician-led support across women's health, men's health, fertility, pregnancy & parenthood, menopause and neurodiversity; says it was the first company worldwide to offer a menopause benefit.

Develops pharmaceuticals and medical devices using proprietary photodynamic technology, with a focus on bladder cancer detection and treatment.

University of Bergen spin-out developing small-molecule pharmacological chaperones for rare genetic disorders; lead program PBAS499 targets phenylketonuria (PKU).

Develops nanopore-based single-molecule protein-sequencing and characterization instruments, spun out of research from the University of Groningen's Maglia Lab.

RNA-editing biotech built around its Axiomer platform, which uses editing oligonucleotides (EONs) to make targeted single-nucleotide corrections to RNA.